Woodmont Investment Counsel LLC Eli Lilly & CO Transaction History

Woodmont Investment Counsel LLC

$1.32 Billion
Q3 2024

A detailed history of Woodmont Investment Counsel LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Woodmont Investment Counsel LLC holds 4,831 shares of LLY stock, worth $3.61 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

4,831

Previous 4,872 0.84%

Holding current value

$3.61 Million

Previous $4.41 Million 2.99%

% of portfolio

0.32%

Previous 0.34%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$772.14 - $960.02 $31,657 - $39,360	-41 Reduced 0.84%	4,831 $4.28 Million
Q2 2024 Jul 18, 2024	BUY	$724.87 - $909.04 $26,820 - $33,634	37 Added 0.77%	4,872 $4.41 Million
Q1 2024 Apr 18, 2024	BUY	$592.2 - $792.28 $43,822 - $58,628	74 Added 1.55%	4,835 $3.76 Million
Q4 2023 Jan 19, 2024	BUY	$525.19 - $619.13 $124,470 - $146,733	237 Added 5.24%	4,761 $2.78 Million
Q3 2023 Oct 24, 2023	SELL	$434.7 - $599.3 $39,992 - $55,135	-92 Reduced 1.99%	4,524 $2.43 Million
Q2 2023 Aug 02, 2023	SELL	$350.74 - $468.98 $145,557 - $194,626	-415 Reduced 8.25%	4,616 $2.16 Million
Q1 2023 May 09, 2023	BUY	$310.63 - $364.82 $96,295 - $113,094	310 Added 6.57%	5,031 $1.73 Million
Q3 2022 Nov 08, 2022	SELL	$296.48 - $337.87 $14,824 - $16,893	-50 Reduced 1.05%	4,721 $1.53 Million
Q2 2022 Aug 09, 2022	BUY	$278.73 - $327.27 $55,746 - $65,454	200 Added 4.38%	4,771 $1.55 Million
Q1 2022 May 12, 2022	SELL	$234.69 - $291.66 $146,681 - $182,287	-625 Reduced 12.03%	4,571 $1.31 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $6,648 - $8,181	-30 Reduced 0.57%	5,196 $1.2 Million
Q1 2021 May 17, 2021	BUY	$164.32 - $212.72 $2,464 - $3,190	15 Added 0.29%	5,226 $976,000
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $56,097 - $74,230	430 Added 8.99%	5,211 $880,000
Q3 2020 Nov 16, 2020	SELL	$146.22 - $169.13 $7,311 - $8,456	-50 Reduced 1.03%	4,781 $708,000
Q2 2020 Aug 14, 2020	SELL	$136.42 - $164.18 $10,231 - $12,313	-75 Reduced 1.53%	4,831 $793,000
Q1 2020 May 15, 2020	SELL	$119.05 - $147.35 $38,691 - $47,888	-325 Reduced 6.21%	4,906 $681,000
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $21,358 - $23,232	-200 Reduced 3.68%	5,231 $585,000
Q2 2019 Aug 14, 2019	BUY	$110.79 - $129.32 $36,006 - $42,029	325 Added 6.37%	5,431 $602,000
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $83,482 - $98,265	-750 Reduced 12.81%	5,106 $663,000
Q4 2018 Feb 14, 2019	SELL	$105.9 - $118.64 $6,354 - $7,118	-60 Reduced 1.01%	5,856 $678,000
Q3 2018 Nov 13, 2018	SELL	$85.86 - $107.31 $6,439 - $8,048	-75 Reduced 1.25%	5,916 $635,000
Q2 2018 Aug 10, 2018	SELL	$75.7 - $86.88 $18,925 - $21,720	-250 Reduced 4.01%	5,991 $511,000
Q1 2018 May 14, 2018	SELL	$74.21 - $87.6 $19,591 - $23,126	-264 Reduced 4.06%	6,241 $483,000
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $501,340 - $556,437	6,505	6,505 $556,000

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodmont Investment Counsel LLC, based on Form 13F filings with the SEC.

News

Stay updated on Woodmont Investment Counsel LLC with notifications on news.

Account

Woodmont Investment Counsel LLC Eli Lilly & CO Transaction History